UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ceftriaxone pharmacokinetics by a sensitive and simple LC–MS/MS method: Development and application

Journal of pharmaceutical and biomedical analysis, 2020-09, Vol.189, p.113484, Article 113484

2020

Volltextzugriff (PDF)

Gender differences in the outcome of community-acquired Staphylococcus aureus bacteraemia: a historical population-based cohort study

Clinical microbiology and infection, 2017-01, Vol.23 (1), p.27-32

2017

Volltextzugriff (PDF)

Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis

Journal of clinical pharmacy and therapeutics, 2018-04, Vol.43 (2), p.220-223

2018

Volltextzugriff (PDF)

Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia?

Journal of antimicrobial chemotherapy, 2015-09, Vol.70 (9), p.2652-2660

2015

Volltextzugriff (PDF)

Ampicillin and Ceftriaxone Solution Stability at Different Temperatures in Outpatient Parenteral Antimicrobial Therapy

Antimicrobial agents and chemotherapy, 2020-06, Vol.64 (7)

2020

Volltextzugriff (PDF)

Impact of the peginterferon-α 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/HIV-co-infected patients with the unfavourable non-CC IL28B genotypes

Journal of viral hepatitis, 2014-03, Vol.21 (3), p.178-188

2014

Volltextzugriff (PDF)

Erratum for Herrera-Hidalgo et al., "Ampicillin and Ceftriaxone Solution Stability at Different Temperatures in Outpatient Parenteral Antimicrobial Therapy"

Antimicrobial agents and chemotherapy, 2021-05, Vol.65 (6)

2021

Volltextzugriff (PDF)

Influence of treatment and immunological recovery on tuberculosis relapses in HIV-infected patients

The international journal of tuberculosis and lung disease, 2005-12, Vol.9 (12), p.1385

2005

Volltextzugriff (PDF)

Vibrios isolated from the cultured manila clam (Ruditapes philippinarum): numerical taxonomy and antibacterial activities

Journal of applied microbiology, 2002-01, Vol.93 (3), p.438-447

2002

Volltextzugriff (PDF)

The Benzodiazepine Dependence Questionnaire (BDEPQ): Validity and reliability in Mexican psychiatric patients

Addictive behaviors, 2011-08, Vol.36 (8), p.874-877

2011

Volltextzugriff (PDF)

Role of Pegylated Interferon-α-2a and Ribavirin Concentrations in Sustained Viral Response in HCV/HIV-Coinfected Patients

Clinical pharmacology and therapeutics, 2008-11, Vol.84 (5), p.573-580

2008

Volltextzugriff (PDF)

Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy

European journal of clinical microbiology & infectious diseases, 2017-03, Vol.36 (3), p.487-494

2017

Volltextzugriff (PDF)

Impact of the peginterferon- alpha 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/HIV-co-infected patients with the unfavourable non-CC IL28B genotypes

Journal of viral hepatitis, 2014-03, Vol.21 (3), p.178-188

2014

Volltextzugriff (PDF)

Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected Patients with tuberculosis

Clinical pharmacokinetics, 2002, Vol.41 (9), p.681-690

2002

Volltextzugriff (PDF)

Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimen

Journal of antimicrobial chemotherapy, 2006-11, Vol.58 (5), p.1017-1023

2006

Volltextzugriff (PDF)

Role of pegylated interferon-alpha-2a and ribavirin concentrations in sustained viral response in HCV/HIV-coinfected patients

Clinical pharmacology and therapeutics, 2008-11, Vol.84 (5), p.573

2008

Volltextzugriff (PDF)

The Use of Transient Elastometry for Assessing Liver Fibrosis in Patients with HIV and Hepatitis C Virus Coinfection

Clinical infectious diseases, 2007-10, Vol.45 (8), p.969-974

2007

Volltextzugriff (PDF)

Corrigendum to “Ceftriaxone pharmacokinetics by a sensitive and simple LC–MS/MS method: Development and application” [J. Pharm. Biomed. Anal. 189 (2020) 113484]

Journal of pharmaceutical and biomedical analysis, 2021-07, Vol.201, p.114098-114098, Article 114098

2021

Volltextzugriff (PDF)

Risk of Liver Decompensation Among HIV/Hepatitis C Virus–Coinfected Individuals With Advanced Fibrosis: Implications for the Timing of Therapy

Clinical infectious diseases, 2013-11, Vol.57 (10), p.1401-1408

2013

Volltextzugriff (PDF)

Digital Necrosis Due to Leishmania Species Infection in a Patient with AIDS

Clinical infectious diseases, 1998-01, Vol.26 (1), p.198-199

1998

Volltextzugriff (PDF)

Reply to Fries et al and Valentin et al

Clinical infectious diseases, 2014-02, Vol.58 (4), p.600-601

2014

Volltextzugriff (PDF)

Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient

Antimicrobial agents and chemotherapy, 1997-05, Vol.41 (5), p.1207-1207

1997

Volltextzugriff (PDF)

A 24-Week Treatment Strategy With Pegylated Interferon/Ribavirin in HIV/Hepatitis C Virus Genotype 3–Coinfected Patients Who Achieved a Rapid Virologic Response Results in a High Sustained Virologic Response Rate

Clinical infectious diseases, 2014-01, Vol.58 (1), p.130-133

2014

Volltextzugriff (PDF)

Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone

Journal of antimicrobial chemotherapy, 2008-12, Vol.62 (6), p.1365-1373

2008

Volltextzugriff (PDF)

Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus–Coinfected Patients With Compensated Liver Cirrhosis

Clinical infectious diseases, 2012-12, Vol.55 (12), p.1719-1726

2012

Volltextzugriff (PDF)

1 – 25 von 225

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(173)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ceftriaxone pharmacokinetics by a sensitive and simple LC–MS/MS method: Development and application

Gender differences in the outcome of community-acquired Staphylococcus aureus bacteraemia: a historical population-based cohort study

Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis

Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia?

Ampicillin and Ceftriaxone Solution Stability at Different Temperatures in Outpatient Parenteral Antimicrobial Therapy

Impact of the peginterferon-α 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/HIV-co-infected patients with the unfavourable non-CC IL28B genotypes

Erratum for Herrera-Hidalgo et al., "Ampicillin and Ceftriaxone Solution Stability at Different Temperatures in Outpatient Parenteral Antimicrobial Therapy"

Influence of treatment and immunological recovery on tuberculosis relapses in HIV-infected patients

Vibrios isolated from the cultured manila clam (Ruditapes philippinarum): numerical taxonomy and antibacterial activities

The Benzodiazepine Dependence Questionnaire (BDEPQ): Validity and reliability in Mexican psychiatric patients

Role of Pegylated Interferon-α-2a and Ribavirin Concentrations in Sustained Viral Response in HCV/HIV-Coinfected Patients

Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy

Impact of the peginterferon- alpha 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/HIV-co-infected patients with the unfavourable non-CC IL28B genotypes

Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected Patients with tuberculosis

Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimen

Role of pegylated interferon-alpha-2a and ribavirin concentrations in sustained viral response in HCV/HIV-coinfected patients

The Use of Transient Elastometry for Assessing Liver Fibrosis in Patients with HIV and Hepatitis C Virus Coinfection

Corrigendum to “Ceftriaxone pharmacokinetics by a sensitive and simple LC–MS/MS method: Development and application” [J. Pharm. Biomed. Anal. 189 (2020) 113484]

Risk of Liver Decompensation Among HIV/Hepatitis C Virus–Coinfected Individuals With Advanced Fibrosis: Implications for the Timing of Therapy

Digital Necrosis Due to Leishmania Species Infection in a Patient with AIDS

Reply to Fries et al and Valentin et al

Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient

A 24-Week Treatment Strategy With Pegylated Interferon/Ribavirin in HIV/Hepatitis C Virus Genotype 3–Coinfected Patients Who Achieved a Rapid Virologic Response Results in a High Sustained Virologic Response Rate

Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone

Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus–Coinfected Patients With Compensated Liver Cirrhosis

Suchergebnisse filtern